Partnering
Icon Bioscience will pursue corporate partnerships and out-licensing agreements of its VerisomeĀ® technology in limited opportunistic circumstances.
We are currently involved with multiple collaborations that involve a wide variety of new chemical entities targeting various ophthalmic indications.Ā These collaborations involve small molecules and biologics.